November 2017 Clinical Trials


A randomized, double-blind, controlled trial on the safety and efficacy of bee propolis 5% ointment versus clobetasol propionate 0.05% ointment for lichen simplex chronicus

Therese Giannine V. Ledesma, MD, DPDS , Eleanor G. Casal-Panis, MD, DPDS Leilani R. Senador, MD, FPDS, Johannes F. Dayrit, MD, FPDS, Ma. Teresita G. Gabriel, MD, FPDS

Lichen simplex chronicus (LSC) is a chronic, pruritic, inflammatory skin condition that occurs in about 3 to 7.1% of the population. Topical corticosteroids like clobetasol propionate 0.05% ointment, are the first-line treatment for acute pruritus associated with inflammatory skin diseases like LSC.